Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.49 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 4/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | NOS3 | P29474 | 2/20 | 0.43 |
| ▸ | NOS1 | P29475 | 2/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | KIF11 | P52732 | 1/20 | 0.42 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8363133 | 0.94 | MAPT (0.57) | EPHX2NR1H4MAPTHPGDKMT2A | |
| SCHEMBL4492464 | 0.94 | MAPT (0.57) | EPHX2NR1H4MAPTHPGDKMT2A | |
| P-Methoxy-Acetophenone SCHEMBL18741339 | 0.87 | MAPT (0.56) | EPHX2NR1H4MAPTHPGDKMT2A | |
| SCHEMBL379246 | 0.85 | ALDH1A1 (0.57) | EPHX2MAPTKMT2ALMNAALDH1A1 | |
| Acetophenone SCHEMBL27509078 | 0.85 | MAPT (0.52) | MAPTHPGDKMT2ALMNARAB9A | |
| SCHEMBL547765 | 0.83 | SRD5A2 (0.59) | MAPTHPGDLMNARAB9ASMN1; SMN2 | |
| SCHEMBL11278492 | 0.83 | MAPT (0.51) | EPHX2NR1H4MAPTHPGDKMT2A | |
| SCHEMBL397829 | 0.83 | EPHX2 (0.65) | EPHX2NR1H4MAPTHPGDKMT2A | |
| SCHEMBL677816 | 0.83 | MAPT (0.50) | EPHX2NR1H4MAPTHPGDKMT2A | |
| SCHEMBL9472225 | 0.83 | HPGD (0.50) | EPHX2NR1H4MAPTHPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0111043-A1 | Stabilised electrical insulating composition | Licentia Patent-Verwaltungs-GmbH (DE) | 1984-06-20 | — | — | EP | claimed |
| EP-0089490-A1 | Insulation stabilized against high voltage | Licentia Patent-Verwaltungs-GmbH (DE) | 1983-09-28 | — | — | EP | claimed |
| US-4088699-A | PRODUCTION OF ARALKYL TERTIARY HYDROPEROXIDES | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1978-05-09 | — | — | US | claimed |
| US-3978142-A | BY ACID REARRANGEMENT 3978142 MOD 3978142 AND CLEAVAGE OF ARALKYL TERTIARY POLYHYDROPEROXIDE | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1976-08-31 | — | — | US | claimed |
| EP-4709725-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | Progentos Therapeutics, Inc. (US) | 2026-03-18 | — | — | EP | disclosed |
| US-12161624-B2 | Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B | NOVARTIS AG (CH) | 2024-12-10 | — | — | US | disclosed |
| WO-2024233642-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | PROGENTOS THERAPEUTICS, INC. (US) | 2024-11-14 | — | — | WO | disclosed |
| US-11852970-B2 | Material for lithography, production method therefor, composition for lithography, pattern formation method, compound, resin, and method for purifying the compound or the resin | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-12-26 | — | — | US | disclosed |
| CN-114685243-B | Green and efficient preparation method of 2-phenyl-2-propanol series compounds | 大连理工大学 | 2023-02-07 | — | — | CN | disclosed |
| US-11572430-B2 | Compound, resin, resist composition or radiation-sensitive composition, resist pattern formation method, method for producing amorphous film, underlayer film forming material for lithography, composition for underlayer film formation for lithography, method for forming circuit pattern, and purification method | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-02-07 | — | — | US | disclosed |
| US-20230012073-A1 | SELECTIVE OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE MODULATORS OF NR2B | CADENT THERAPEUTICS, INC. (US) | 2023-01-12 | — | — | US | disclosed |
| US-20230012073-A1 | SELECTIVE OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE MODULATORS OF NR2B | CADENT THERAPEUTICS, INC. (US) | 2023-01-12 | — | — | US | disclosed |
| EP-0111043-A1 | Stabilised electrical insulating composition | Licentia Patent-Verwaltungs-GmbH (DE) | 1984-06-20 | — | — | EP | disclosed |
| US-4307223-A | CONTAINING PHENOLIC CONSTITUENTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-12-22 | — | — | US | disclosed |
| US-4152294-A | MULTISTAGE PREPARATION AND PURIFICATION OF P-DIISOPROPYLBENZENE MONOHYDROPEROXIDE, AQUEOUS EMULSION POLYMERIZATION | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1979-05-01 | — | — | US | disclosed |
| US-4152293-A | MULTISTAGE PREPARATION AND PURIFICATION OF P-DIISOPROPYLBENZENE MONOHYDROPEROXIDE | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1979-05-01 | — | — | US | disclosed |
| US-4136123-A | ALKALI METAL SULFONATE DERIVATIVES | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1979-01-23 | — | — | US | disclosed |
| US-4088699-A | PRODUCTION OF ARALKYL TERTIARY HYDROPEROXIDES | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1978-05-09 | — | — | US | disclosed |
| US-4080386-A | OXIDATION OF AN ARYL TERTIARY ALKANE, TREATING RECYCLE STREAM WITH AN ALKALINE EXTRACTANT | THE GOODYEAR TIRE & RUBBER CO. (US) | 1978-03-21 | — | — | US | disclosed |
| US-3978142-A | BY ACID REARRANGEMENT 3978142 MOD 3978142 AND CLEAVAGE OF ARALKYL TERTIARY POLYHYDROPEROXIDE | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11852970-B2 | Material for lithography, production method therefor, composition for lithography, pattern formation method, compound, resin, and method for purifying the compound or the resin | SLC39A11, CROCC, TERB1 | EPHX2 1686/4885NR1H4 851/4885MAPT 1634/4885 |
| US-20230012073-A1 | SELECTIVE OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE MODULATORS OF NR2B | GRIN2A, GRIN2C, GRIN3A | EPHX2 3355/4885NR1H4 97/4885MAPT 1173/4885 |
| US-11572430-B2 | Compound, resin, resist composition or radiation-sensitive composition, resist pattern formation method, method for producing amorphous film, underlayer film forming material for lithography, composition for underlayer film formation for lithography, method for forming circuit pattern, and purification method | C9, C5, C1R | EPHX2 473/4885NR1H4 749/4885MAPT 3986/4885 |
| US-12161624-B2 | Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B | GRIN2A, GRIN2C, GRIN3A | EPHX2 3355/4885NR1H4 97/4885MAPT 1173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.